Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Antitumor agent-21 (TRX818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 約4-6 週間 | ¥ 9,500 |
2 mg | 約4-6 週間 | ¥ 13,000 |
5 mg | 約4-6 週間 | ¥ 22,500 |
10 mg | 約4-6 週間 | ¥ 36,500 |
25 mg | 約4-6 週間 | ¥ 55,000 |
50 mg | 約4-6 週間 | ¥ 85,000 |
説明 | Antitumor agent-21 (TRX818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities. |
別名 | TRX818 |
分子量 | 545.49 |
分子式 | C30H25FNO6P |
CAS No. | 1256037-58-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mM
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Antitumor agent-21 1256037-58-7 Others TRX818 Antitumor agent21 aryl-quinolin Antitumor agent 21 TRX-818 inhibit derivative Inhibitor TRX 818 inhibitor